- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers in localized prostate cancer
Authors
Keywords
-
Journal
Future Oncology
Volume 12, Issue 3, Pages 399-411
Publisher
Future Medicine Ltd
Online
2016-01-15
DOI
10.2217/fon.15.318
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of enhancer of zeste homolog 2 (EZH2) characterizes an aggressive subset of prostate cancers and predicts patient prognosis independently from pre- and postoperatively assessed clinicopathological parameters
- (2015) Nathaniel Melling et al. CARCINOGENESIS
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case–Control Study
- (2015) Pär Stattin et al. EUROPEAN UROLOGY
- A Biopsy-based 17-gene Genomic Prostate Score Predicts Recurrence After Radical Prostatectomy and Adverse Surgical Pathology in a Racially Diverse Population of Men with Clinically Low- and Intermediate-risk Prostate Cancer
- (2015) Jennifer Cullen et al. EUROPEAN UROLOGY
- Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer
- (2015) Giuseppe Lucarelli et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
- (2015) Richard J. Bryant et al. JNCI-Journal of the National Cancer Institute
- Predictive role of free prostate-specific antigen in a prospective active surveillance program (PRIAS)
- (2015) Hanna Vasarainen et al. WORLD JOURNAL OF UROLOGY
- Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study
- (2015) Richard J. Bryant et al. JNCI-Journal of the National Cancer Institute
- Screening for Prostate Cancer—Beyond Total PSA, Utilization of Novel Biomarkers
- (2015) Todd Morgan et al. Current Urology Reports
- DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer
- (2015) Kirill Litovkin et al. PLoS One
- Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis
- (2014) K. S. Louie et al. ANNALS OF ONCOLOGY
- The PCA3 test for guiding repeat biopsy of prostate cancer and its cut-off score: a systematic review and meta-analysis
- (2014) Xin Gou et al. ASIAN JOURNAL OF ANDROLOGY
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study
- (2014) Elizabeth K. Bancroft et al. EUROPEAN UROLOGY
- Prognostic DNA Methylation Markers for Prostate Cancer
- (2014) Siri Strand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data
- (2014) E. A. M. Heijnsdijk et al. JNCI-Journal of the National Cancer Institute
- Clinical Validation of an Epigenetic Assay to Predict Negative Histopathological Results in Repeat Prostate Biopsies
- (2014) Alan W. Partin et al. JOURNAL OF UROLOGY
- Prognostic Value of RASSF1 Promoter Methylation in Prostate Cancer
- (2014) Kristina Daniunaite et al. JOURNAL OF UROLOGY
- Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
- (2014) Fritz H Schröder et al. LANCET
- Prostate health index vs percent free prostate-specific antigen for prostate cancer detection in men with “gray” prostate-specific antigen levels at first biopsy: systematic review and meta-analysis
- (2014) Dario Bruzzese et al. Translational Research
- Prostate Cancer Prevention Trial Risk Calculator 2.0 for the Prediction of Low- vs High-grade Prostate Cancer
- (2014) Donna P. Ankerst et al. UROLOGY
- Clinical performance of serum prostate-specific antigen isoform [-2]proPSA (p2PSA) and its derivatives, %p2PSA and the prostate health index (PHI), in men with a family history of prostate cancer: results from a multicentre European study, the PROMEtheuS
- (2013) Massimo Lazzeri et al. BJU INTERNATIONAL
- Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial
- (2013) S. Koutros et al. CARCINOGENESIS
- Genetic Variation in KLK2 and KLK3 Is Associated with Concentrations of hK2 and PSA in Serum and Seminal Plasma in Young Men
- (2013) C. Savblom et al. CLINICAL CHEMISTRY
- Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam
- (2013) Sigrid Carlsson et al. EUROPEAN UROLOGY
- Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer
- (2013) Giuseppe Lucarelli et al. Future Oncology
- The impact of baseline [−2]proPSA-related indices on the prediction of pathological reclassification at 1 year during active surveillance for low-risk prostate cancer: the Japanese multicenter study cohort
- (2013) Hiromi Hirama et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort
- (2013) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Spondin-2, a Secreted Extracellular Matrix Protein, is a Novel Diagnostic Biomarker for Prostate Cancer
- (2013) Giuseppe Lucarelli et al. JOURNAL OF UROLOGY
- Early Detection of Prostate Cancer: AUA Guideline
- (2013) H. Ballentine Carter et al. JOURNAL OF UROLOGY
- Prostate Specific Antigen Velocity Risk Count Predicts Biopsy Reclassification for Men with Very Low Risk Prostate Cancer
- (2013) Hiten D. Patel et al. JOURNAL OF UROLOGY
- Relationship of Chronic Histologic Prostatic Inflammation in Biopsy Specimens With Serum Isoform [-2]proPSA (p2PSA), %p2PSA, and Prostate Health Index in Men With a Total Prostate-specific Antigen of 4-10 ng/mL and Normal Digital Rectal Examination
- (2013) Massimo Lazzeri et al. UROLOGY
- Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort
- (2012) J Cuzick et al. BRITISH JOURNAL OF CANCER
- miRNAs as biomarkers in prostate cancer
- (2012) Irene Casanova-Salas et al. Clinical & Translational Oncology
- DNA methylation biomarkers and their utility for solid cancer diagnostics
- (2012) Karen A. Heichman et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
- (2012) Himisha Beltran et al. EUROPEAN UROLOGY
- Association of [−2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer
- (2012) Jeffrey J. Tosoian et al. JOURNAL OF UROLOGY
- CpG Island Hypermethylation Frequently Silences FILIP1L Isoform 2 Expression in Prostate Cancer
- (2012) Joshua Desotelle et al. JOURNAL OF UROLOGY
- Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
- (2012) Grant D. Stewart et al. JOURNAL OF UROLOGY
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Quality-of-Life Effects of Prostate-Specific Antigen Screening
- (2012) Eveline A.M. Heijnsdijk et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer
- (2012) Jing Shen et al. PROSTATE
- Rational basis for the combination of PCA3 and TMPRSS2:ERG gene fusion for prostate cancer diagnosis
- (2012) Grégoire Robert et al. PROSTATE
- Serum sarcosine increases the accuracy of prostate cancer detection in patients with total serum PSA less than 4.0 ng/ml
- (2012) Giuseppe Lucarelli et al. PROSTATE
- The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume
- (2011) Niall M. Corcoran et al. BJU INTERNATIONAL
- The CAPRA-S score
- (2011) Matthew R. Cooperberg et al. CANCER
- mRNA Expression Signature of Gleason Grade Predicts Lethal Prostate Cancer
- (2011) Kathryn L. Penney et al. JOURNAL OF CLINICAL ONCOLOGY
- An Empirical Evaluation of Guidelines on Prostate-specific Antigen Velocity in Prostate Cancer Detection
- (2011) Andrew J. Vickers et al. JNCI-Journal of the National Cancer Institute
- Efforts to resolve the contradictions in early diagnosis of prostate cancer: a comparison of different algorithms of sarcosine in urine
- (2011) D-L Cao et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Combining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer
- (2011) Simpa S. Salami et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Circulating microRNAs (miRNA) in Serum of Patients With Prostate Cancer
- (2011) Robert Mahn et al. UROLOGY
- A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France
- (2010) Amine Benchikh et al. BMC CANCER
- A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
- (2010) A Gupta et al. BRITISH JOURNAL OF CANCER
- A Prospective, Multicenter, National Cancer Institute Early Detection Research Network Study of [-2]proPSA: Improving Prostate Cancer Detection and Correlating with Cancer Aggressiveness
- (2010) L. J. Sokoll et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
- (2010) Flip H. Jansen et al. EUROPEAN UROLOGY
- A multiplex model of combining gene-based, protein-based, and metabolite-based with positive and negative markers in urine for the early diagnosis of prostate cancer
- (2010) Da-Long Cao et al. PROSTATE
- TMPRSS2-ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african-american and japanese patients
- (2010) Cristina Magi-Galluzzi et al. PROSTATE
- Prostate-specific antigen (PSA) kinetics in untreated, localized prostate cancer: PSA velocity vs PSA doubling time
- (2009) Michael K. Ng et al. BJU INTERNATIONAL
- Prostate Specific Antigen Density to Predict Prostate Cancer Upgrading in a Contemporary Radical Prostatectomy Series: A Single Center Experience
- (2009) Ahmed Magheli et al. JOURNAL OF UROLOGY
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
- (2009) Arun Sreekumar et al. NATURE
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
- (2008) Andrew J Vickers et al. BMC Medicine
- A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
- (2008) B. Laxman et al. CANCER RESEARCH
- Predicting the Probability of Deferred Radical Treatment for Localised Prostate Cancer Managed by Active Surveillance
- (2008) Nicholas J. van As et al. EUROPEAN UROLOGY
- Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer
- (2008) Andrew J. Vickers et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Detection of Prostate Cancer in 2007
- (2007) Fritz H. Schröder et al. EUROPEAN UROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started